Wang et al have recently demonstrated that SKP2 is a dynamic key regulator that acts as an important functional switch between autoreactive pathogenic T cells and Tregs.[25] Our study showed that SKP2 expression in cancer cells is significantly associated with infiltrated FOXP3 + Tregs in gastric adenocarcinoma. This evidence concerns the gene SKP2 and cancer.